Chargement en cours...
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
The novel beta coronavirus (SARS-CoV-2, designated as COVID-19) that is responsible for severe acute respiratory syndrome has devastated the global economy and health care system. Since COVID-19 changed the definition of “normal” in ordinary life around the world, the development of effective therap...
Enregistré dans:
| Publié dans: | Arch Pharm Res |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pharmaceutical Society of Korea
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7781412/ https://ncbi.nlm.nih.gov/pubmed/33398692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12272-020-01301-7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|